A phase III, randomized, double-blind, active, controlled, multinational, multicentre, non-inferiority trial using carbetocin room temperature stable (RTS) for the prevention of postpartum haemorrhage during the third stage of labour in women delivering vaginally

Trial Profile

A phase III, randomized, double-blind, active, controlled, multinational, multicentre, non-inferiority trial using carbetocin room temperature stable (RTS) for the prevention of postpartum haemorrhage during the third stage of labour in women delivering vaginally

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Jun 2018

At a glance

  • Drugs Carbetocin (Primary) ; Oxytocin
  • Indications Postpartum haemorrhage
  • Focus Therapeutic Use
  • Acronyms CHAMPION
  • Most Recent Events

    • 27 Jun 2018 Results published in the Merck Media Release
    • 27 Jun 2018 According to Merck Media release, Results from this trial led by the World Health Organization (WHO) and conducted as part of a public-private collaboration with Ferring and Merck for Mothers, were published in the New England Journal of Medicine(NEJM).
    • 26 Feb 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top